TP53 regulates miRNA association with AGO2 to remodel the miRNA-mRNA interaction network

Genome Research

Volumn 26, Issue 3, 2016, Pages 331-341

  Krell, Jonathan ^a   Stebbing, Justin ^a   Carissimi, Claudia ^b   Dabrowska, Aleksandra F ^a   Giorgio, Alexander De ^a   Frampton, Adam E ^c   Harding, Victoria ^a   Fulci, Valerio ^b   Macino, Giuseppe ^b   Colombo, Teresa ^d,e   Castellano, Leandro ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d CNR   (Italy)

^e UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; MICRORNA; PROTEIN P53; ARGONAUTE PROTEIN; DOXORUBICIN; EIF2C2 PROTEIN, HUMAN; MESSENGER RNA; PROTEIN BINDING;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; BIOGENESIS; CANCER GROWTH; CARCINOGENESIS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA DAMAGE; DNA SEQUENCE; GENETIC CONSERVATION; HUMAN; HUMAN CELL; MUTATION; PRIORITY JOURNAL; PROTEIN RNA BINDING; RNA SYNTHESIS; TRANSCRIPTION REGULATION; DOUBLE STRANDED DNA BREAK; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

ARGONAUTE PROTEINS; CELL LINE, TUMOR; DNA BREAKS, DOUBLE-STRANDED; DOXORUBICIN; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; PROTEIN BINDING; RNA INTERFERENCE; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84960464881     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.191759.115     Document Type: Article

References (41)

1. Bailey TL, Johnson J, Grant CE, Noble WS. 2015. The MEME Suite. Nucleic Acids Res 43:W39-W49.
2. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.
3. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. JRoy Statist Soc B Met 57:289-300.
4. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME. 2010. The roleof let-7 in cell differentiation and cancer. Endocr Relat Cancer 17:F19-F36.
5. Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, Barton G, Jiao LR, Wait R, Waxman J, et al. 2009. The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci 106:15732-15737.
6. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al. 2007. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26:745-752.
7. Chi SW, Zang JB, Mele A, Darnell RB. 2009. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460:479-486.
8. Chi SW, Hannon GJ, Darnell RB. 2012. An alternative mode of microRNA target recognition. Nat Struct Mol Biol 19:321-327.
9. Choudhry H, Albukhari A, Morotti M, Haider S, Moralli D, Smythies J, Schödel J, Green CM, Camps C, Buffa F, et al. 2015. Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival. Oncogene 34:4482-4490.
10. Clark PM, Loher P, Quann K, Brody J, Londin ER, Rigoutsos I. 2014. Argonaute CLIP-Seq reveals miRNA targetome diversity across tissue types. Sci Rep 4:5947.
11. Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A, Lawrence JB. 2009. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell 33:717-726.
12. Corcoran DL, Georgiev S, Mukherjee N, Gottwein E, Skalsky RL, Keene JD, Ohler U. 2011. PARalyzer: definition of RNA binding sites from PAR-CLIP short-read sequence data. Genome Biol 12:R79.
13. De Giorgio A, Krell J, Harding V, Stebbing J, Castellano L. 2013. Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN. Mol Cell Biol 33:3976-3982.
14. Francia S, Michelini F, Saxena A, Tang D, De Hoon M, Anelli V, Mione M, Carninci P, D'Adda Di Fagagna F. 2012. Site-specific DICER and DROSHA RNA products control the DNA-damage response. Nature 488:231-235.
15. Grosswendt S, Filipchyk A, Manzano M, Klironomos F, Schilling M, Herzog M, Gottwein E, Rajewsky N. 2014. Unambiguous identification of miRNA: target site interactions by different types of ligation reactions. Mol Cell 54:1042-1054.
16. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, Rothballer A, Ascano M Jr, Jungkamp AC, Munschauer M, et al. 2010. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141:129-141.
17. He L, He X, Lim LP, De Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al. 2007. A microRNA component of the p53 tumour suppressor network. Nature 447:1130-1134.
18. Helwak A, Tollervey D. 2014. Mapping the miRNA interactome by crosslinking ligation and sequencing of hybrids (CLASH). Nat Protoc 9:711-728.
19. Helwak A, Kudla G, Dudnakova T, Tollervey D. 2013. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153:654-665.
20. Hollstein M, Sidransky D, Vogelstein B, Harris CC. 1991. p53 mutations in human cancers. Science 253:49-53.
21. Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, et al. 2011. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 43:621-629.
22. Konig J, Zarnack K, Rot G, Curk T, Kayikci M, Zupan B, Turner DJ, Luscombe NM, Ule J. 2011. iCLIP-transcriptome-wide mapping of protein-RNA interactions with individual nucleotide resolution. J Vis Exp doi: 10.3791/2638.
23. Krell J, Frampton AE, Colombo T, Gall TM, De Giorgio A, Harding V, Stebbing J, Castellano L. 2013. The p53 miRNA interactome and its potential role in the cancer clinic. Epigenomics 5:417-428.
24. Krell J, Frampton AE, Mirnezami R, Harding V, De Giorgio A, Roca Alonso L, Cohen P, Ottaviani S, Colombo T, Jacob J, et al. 2014. Growth arrest-specific transcript 5 associated snoRNA levels are related to p53 expression and DNA damage in colorectal cancer. PLoS One 9:e98561.
25. Kruiswijk F, Labuschagne CF, Vousden KH. 2015. p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol 16:393-405.
26. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ, Marra MA. 2009. Circos: an information aesthetic for comparative genomics. Genome Res 19:1639-1645.
27. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
28. Liu DP, Song H, Xu Y. 2010. A common gain of function of p53 cancer mutants in inducing genetic instability. Oncogene 29:949-956.
29. Lunardi A, Di Minin G, Provero P, Dal Ferro M, Carotti M, Del Sal G, Collavin L. 2010. A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network. Proc Natl Acad Sci 107:6322-6327.
30. Lytle JR, Yario TA, Steitz JA. 2007. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci 104:9667-9672.
31. Menendez D, Inga A, Resnick MA. 2009. The expanding universe of p53 targets. Nat Rev Cancer 9:724-737.
32. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. 2005. c-Mycregulated microRNAs modulate E2F1 expression. Nature 435:839-843.
33. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. 2010. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465:1033-1038.
34. ∗ in glioblastoma stem cells. EMBO J 30:4309-4322.
35. Shen J, Xia W, Khotskaya YB, Huo L, Nakanishi K, Lim SO, Du Y, Wang Y, Chang WC, Chen CH, et al. 2013. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497:383-387.
36. Sigal A, Rotter V. 2000. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res 60:6788-6793.
37. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. 2009. Modulation of microRNA processing by p53. Nature 460:529-533.
38. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I. 2008. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455:1124-1128.
39. Tsang J, Zhu J, Van Oudenaarden A. 2007. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell 26:753-767.
40. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z, et al. 2006. A global map of p53 transcription-factor binding sites in the human genome. Cell 124:207-219.
41. Yu G, Wang LG, Han Y, He QY. 2012. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16:284-287.